APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Finasteride

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Finasteride Market Outlook and Growth Opportunities 2026

Report ID 173991900423 December 2025194 pages

Choose your research edition.

Industry ResearchFinasteride Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Finasteride Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Finasteride Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Finasteride Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Finasteride Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Finasteride market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Finasteride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Finasteride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Finasteride is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Finasteride market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Finasteride market include Teva Pharmaceuticals, Sandoz, Shandong Renhetang Pharmaceutical, Merck, Zhejiang CONBA Pharmaceutical, Henan Topfond, Guangdong Eashu Pharmacetical, RelonChem and Dr. Reddy, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Finasteride market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Finasteride and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Finasteride sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Finasteride market size, projected growth trends, production technologies, key applications, and end-use industries.

Finasteride Segment by Company

Teva Pharmaceuticals

Sandoz

Shandong Renhetang Pharmaceutical

Merck

Zhejiang CONBA Pharmaceutical

Henan Topfond

Guangdong Eashu Pharmacetical

RelonChem

Dr. Reddy

Cipla

Actavis

Accord Pharmaceuticals

Finasteride Segment by Type

1mg Tablet

5mg Tablet

Finasteride Segment by Application

Medical Uses

Application 2

Finasteride Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Finasteride status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Finasteride market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Finasteride significant trends, drivers, influence factors in global and regions.

6. To analyze Finasteride competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Finasteride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Finasteride and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Finasteride.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Finasteride market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Finasteride industry.

Chapter 3: Detailed analysis of Finasteride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Finasteride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Finasteride in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Finasteride Industry Trends Table 2. Finasteride Industry Drivers Table 3. Finasteride Industry Opportunities and Challenges Table 4. Finasteride Industry Restraints Table 5. Global Finasteride Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Finasteride Revenue Share by Company (2021-2026) Table 7. Global Finasteride Sales Volume by Company (tons) & (2021-2026) Table 8. Global Finasteride Sales Volume Share by Company (2021-2026) Table 9. Global Finasteride Average Price (US$/kg) of Company (2021-2026) Table 10. Global Finasteride Company Ranking, (2024-2026) & (USD Million) Table 11. Global Finasteride Key Company Manufacturing Base & Headquarters Table 12. Global Finasteride Company, Product Type & Application Table 13. Global Finasteride Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Finasteride by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 1mg Tablet Table 18. Significant Companies of 5mg Tablet Table 19. Global Finasteride Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 20. Global Finasteride Sales Volume by Type (2021-2026) & (tons) Table 21. Global Finasteride Sales Volume by Type (2027-2032) & (tons) Table 22. Global Finasteride Sales Volume Share by Type (2021-2026) Table 23. Global Finasteride Sales Volume Share by Type (2027-2032) Table 24. Global Finasteride Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Finasteride Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Finasteride Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Finasteride Sales Value Share by Type (2021-2026) Table 28. Global Finasteride Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Medical Uses Table 30. Significant Companies of Application 2 Table 31. Global Finasteride Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 32. Global Finasteride Sales Volume by Application (2021-2026) & (tons) Table 33. Global Finasteride Sales Volume by Application (2027-2032) & (tons) Table 34. Global Finasteride Sales Volume Share by Application (2021-2026) Table 35. Global Finasteride Sales Volume Share by Application (2027-2032) Table 36. Global Finasteride Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Finasteride Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Finasteride Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Finasteride Sales Value Share by Application (2021-2026) Table 40. Global Finasteride Sales Value Share by Application (2027-2032) Table 41. Global Finasteride Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 42. Global Finasteride Sales by Region (2021-2026) & (tons) Table 43. Global Finasteride Sales Market Share by Region (2021-2026) Table 44. Global Finasteride Sales by Region (2027-2032) & (tons) Table 45. Global Finasteride Sales Market Share by Region (2027-2032) Table 46. Global Finasteride Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Finasteride Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Finasteride Sales Value Share by Region (2021-2026) Table 49. Global Finasteride Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Finasteride Sales Value Share by Region (2027-2032) Table 51. Global Finasteride Market Average Price (US$/kg) by Region (2021-2026) Table 52. Global Finasteride Market Average Price (US$/kg) by Region (2027-2032) Table 53. Global Finasteride Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 54. Global Finasteride Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Finasteride Sales by Country (2021-2026) & (tons) Table 56. Global Finasteride Sales Market Share by Country (2021-2026) Table 57. Global Finasteride Sales by Country (2027-2032) & (tons) Table 58. Global Finasteride Sales Market Share by Country (2027-2032) Table 59. Global Finasteride Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Finasteride Sales Value Market Share by Country (2021-2026) Table 61. Global Finasteride Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Finasteride Sales Value Market Share by Country (2027-2032) Table 63. Teva Pharmaceuticals Company Information Table 64. Teva Pharmaceuticals Business Overview Table 65. Teva Pharmaceuticals Finasteride Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 66. Teva Pharmaceuticals Finasteride Product Portfolio Table 67. Teva Pharmaceuticals Recent Development Table 68. Sandoz Company Information Table 69. Sandoz Business Overview Table 70. Sandoz Finasteride Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 71. Sandoz Finasteride Product Portfolio Table 72. Sandoz Recent Development Table 73. Shandong Renhetang Pharmaceutical Company Information Table 74. Shandong Renhetang Pharmaceutical Business Overview Table 75. Shandong Renhetang Pharmaceutical Finasteride Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 76. Shandong Renhetang Pharmaceutical Finasteride Product Portfolio Table 77. Shandong Renhetang Pharmaceutical Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Finasteride Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 81. Merck Finasteride Product Portfolio Table 82. Merck Recent Development Table 83. Zhejiang CONBA Pharmaceutical Company Information Table 84. Zhejiang CONBA Pharmaceutical Business Overview Table 85. Zhejiang CONBA Pharmaceutical Finasteride Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 86. Zhejiang CONBA Pharmaceutical Finasteride Product Portfolio Table 87. Zhejiang CONBA Pharmaceutical Recent Development Table 88. Henan Topfond Company Information Table 89. Henan Topfond Business Overview Table 90. Henan Topfond Finasteride Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 91. Henan Topfond Finasteride Product Portfolio Table 92. Henan Topfond Recent Development Table 93. Guangdong Eashu Pharmacetical Company Information Table 94. Guangdong Eashu Pharmacetical Business Overview Table 95. Guangdong Eashu Pharmacetical Finasteride Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 96. Guangdong Eashu Pharmacetical Finasteride Product Portfolio Table 97. Guangdong Eashu Pharmacetical Recent Development Table 98. RelonChem Company Information Table 99. RelonChem Business Overview Table 100. RelonChem Finasteride Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 101. RelonChem Finasteride Product Portfolio Table 102. RelonChem Recent Development Table 103. Dr. Reddy Company Information Table 104. Dr. Reddy Business Overview Table 105. Dr. Reddy Finasteride Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 106. Dr. Reddy Finasteride Product Portfolio Table 107. Dr. Reddy Recent Development Table 108. Cipla Company Information Table 109. Cipla Business Overview Table 110. Cipla Finasteride Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 111. Cipla Finasteride Product Portfolio Table 112. Cipla Recent Development Table 113. Actavis Company Information Table 114. Actavis Business Overview Table 115. Actavis Finasteride Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 116. Actavis Finasteride Product Portfolio Table 117. Actavis Recent Development Table 118. Accord Pharmaceuticals Company Information Table 119. Accord Pharmaceuticals Business Overview Table 120. Accord Pharmaceuticals Finasteride Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 121. Accord Pharmaceuticals Finasteride Product Portfolio Table 122. Accord Pharmaceuticals Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Finasteride Distributors List Table 126. Finasteride Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Finasteride Product Image Figure 2. Global Finasteride Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Finasteride Sales Value (2021-2032) & (US$ Million) Figure 4. Global Finasteride Sales (2021-2032) & (tons) Figure 5. Global Finasteride Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Finasteride Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 1mg Tablet Image Figure 10. 5mg Tablet Image Figure 11. Global Finasteride Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 12. Global Finasteride Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Finasteride Sales Volume Share by Type (2021-2032) Figure 14. Global Finasteride Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Finasteride Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Finasteride Sales Value Share by Type (2021-2032) Figure 17. Medical Uses Image Figure 18. Application 2 Image Figure 19. Global Finasteride Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 20. Global Finasteride Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Finasteride Sales Volume Share by Application (2021-2032) Figure 22. Global Finasteride Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Finasteride Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Finasteride Sales Value Share by Application (2021-2032) Figure 25. Global Finasteride Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 26. Global Finasteride Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Finasteride Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Finasteride Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Finasteride Sales Value (2021-2032) & (US$ Million) Figure 30. North America Finasteride Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Finasteride Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Finasteride Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Finasteride Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Finasteride Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Finasteride Sales Value (2021-2032) & (US$ Million) Figure 36. South America Finasteride Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Finasteride Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Finasteride Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Finasteride Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Finasteride Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Finasteride Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Finasteride Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Finasteride Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg Tablet
  • 5mg Tablet
Applications
  • Medical Uses
  • Application 2
Companies covered
  • Teva Pharmaceuticals
  • Sandoz
  • Shandong Renhetang Pharmaceutical
  • Merck
  • Zhejiang CONBA Pharmaceutical
  • Henan Topfond
  • Guangdong Eashu Pharmacetical
  • RelonChem
  • Dr. Reddy
  • Cipla
  • Actavis
  • Accord Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Finasteride Sales Value (2021-2032)
  4. 1.2.2 Global Finasteride Sales Volume (2021-2032)
  5. 1.2.3 Global Finasteride Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Finasteride Market Dynamics
  1. 2.1 Finasteride Industry Trends
  2. 2.2 Finasteride Industry Drivers
  3. 2.3 Finasteride Industry Opportunities and Challenges
  4. 2.4 Finasteride Industry Restraints
3 Finasteride Market by Company
  1. 3.1 Global Finasteride Company Revenue Ranking in 2025
  2. 3.2 Global Finasteride Revenue by Company (2021-2026)
  3. 3.3 Global Finasteride Sales Volume by Company (2021-2026)
  4. 3.4 Global Finasteride Average Price by Company (2021-2026)
  5. 3.5 Global Finasteride Company Ranking (2024-2026)
  6. 3.6 Global Finasteride Company Manufacturing Base and Headquarters
  7. 3.7 Global Finasteride Company Product Type and Application
  8. 3.8 Global Finasteride Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Finasteride Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Finasteride Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Finasteride Market by Type
  1. 4.1 Finasteride Type Introduction
  2. 4.1.1 1mg Tablet
  3. 4.1.2 5mg Tablet
  4. 4.2 Global Finasteride Sales Volume by Type
  5. 4.2.1 Global Finasteride Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Finasteride Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Finasteride Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Finasteride Sales Value by Type
  9. 4.3.1 Global Finasteride Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Finasteride Sales Value by Type (2021-2032)
  11. 4.3.3 Global Finasteride Sales Value Share by Type (2021-2032)
5 Finasteride Market by Application
  1. 5.1 Finasteride Application Introduction
  2. 5.1.1 Medical Uses
  3. 5.1.2 Application 2
  4. 5.2 Global Finasteride Sales Volume by Application
  5. 5.2.1 Global Finasteride Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Finasteride Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Finasteride Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Finasteride Sales Value by Application
  9. 5.3.1 Global Finasteride Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Finasteride Sales Value by Application (2021-2032)
  11. 5.3.3 Global Finasteride Sales Value Share by Application (2021-2032)
6 Finasteride Regional Sales and Value Analysis
  1. 6.1 Global Finasteride Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Finasteride Sales by Region (2021-2032)
  3. 6.2.1 Global Finasteride Sales by Region: 2021-2026
  4. 6.2.2 Global Finasteride Sales by Region (2027-2032)
  5. 6.3 Global Finasteride Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Finasteride Sales Value by Region (2021-2032)
  7. 6.4.1 Global Finasteride Sales Value by Region: 2021-2026
  8. 6.4.2 Global Finasteride Sales Value by Region (2027-2032)
  9. 6.5 Global Finasteride Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Finasteride Sales Value (2021-2032)
  12. 6.6.2 North America Finasteride Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Finasteride Sales Value (2021-2032)
  15. 6.7.2 Europe Finasteride Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Finasteride Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Finasteride Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Finasteride Sales Value (2021-2032)
  21. 6.9.2 South America Finasteride Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Finasteride Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Finasteride Sales Value Share by Country, 2025 VS 2032
7 Finasteride Country-level Sales and Value Analysis
  1. 7.1 Global Finasteride Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Finasteride Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Finasteride Sales by Country (2021-2032)
  4. 7.3.1 Global Finasteride Sales by Country (2021-2026)
  5. 7.3.2 Global Finasteride Sales by Country (2027-2032)
  6. 7.4 Global Finasteride Sales Value by Country (2021-2032)
  7. 7.4.1 Global Finasteride Sales Value by Country (2021-2026)
  8. 7.4.2 Global Finasteride Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Finasteride Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Finasteride Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Finasteride Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Finasteride Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Finasteride Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Finasteride Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Finasteride Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Finasteride Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Finasteride Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Finasteride Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Finasteride Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Finasteride Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Finasteride Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Finasteride Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Finasteride Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Finasteride Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Finasteride Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Finasteride Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Finasteride Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Finasteride Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Finasteride Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Finasteride Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Finasteride Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Finasteride Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Finasteride Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Finasteride Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Finasteride Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Finasteride Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Finasteride Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Finasteride Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Finasteride Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Finasteride Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Finasteride Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Finasteride Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Finasteride Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Finasteride Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Finasteride Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Finasteride Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Finasteride Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Finasteride Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Finasteride Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Finasteride Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Finasteride Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Finasteride Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Finasteride Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Finasteride Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Finasteride Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Finasteride Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Finasteride Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Finasteride Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Finasteride Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Finasteride Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Finasteride Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Finasteride Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Finasteride Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Finasteride Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Finasteride Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Finasteride Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Finasteride Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Finasteride Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Finasteride Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Finasteride Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Finasteride Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Finasteride Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Finasteride Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Finasteride Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Finasteride Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Finasteride Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Finasteride Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Finasteride Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Finasteride Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Finasteride Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Finasteride Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Finasteride Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Finasteride Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Finasteride Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Finasteride Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Finasteride Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Finasteride Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Finasteride Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Finasteride Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Finasteride Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Finasteride Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Finasteride Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceuticals
  2. 8.1.1 Teva Pharmaceuticals Company Information
  3. 8.1.2 Teva Pharmaceuticals Business Overview
  4. 8.1.3 Teva Pharmaceuticals Finasteride Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceuticals Finasteride Product Portfolio
  6. 8.1.5 Teva Pharmaceuticals Recent Developments
  7. 8.2 Sandoz
  8. 8.2.1 Sandoz Company Information
  9. 8.2.2 Sandoz Business Overview
  10. 8.2.3 Sandoz Finasteride Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz Finasteride Product Portfolio
  12. 8.2.5 Sandoz Recent Developments
  13. 8.3 Shandong Renhetang Pharmaceutical
  14. 8.3.1 Shandong Renhetang Pharmaceutical Company Information
  15. 8.3.2 Shandong Renhetang Pharmaceutical Business Overview
  16. 8.3.3 Shandong Renhetang Pharmaceutical Finasteride Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Renhetang Pharmaceutical Finasteride Product Portfolio
  18. 8.3.5 Shandong Renhetang Pharmaceutical Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Finasteride Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck Finasteride Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Zhejiang CONBA Pharmaceutical
  26. 8.5.1 Zhejiang CONBA Pharmaceutical Company Information
  27. 8.5.2 Zhejiang CONBA Pharmaceutical Business Overview
  28. 8.5.3 Zhejiang CONBA Pharmaceutical Finasteride Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Zhejiang CONBA Pharmaceutical Finasteride Product Portfolio
  30. 8.5.5 Zhejiang CONBA Pharmaceutical Recent Developments
  31. 8.6 Henan Topfond
  32. 8.6.1 Henan Topfond Company Information
  33. 8.6.2 Henan Topfond Business Overview
  34. 8.6.3 Henan Topfond Finasteride Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Henan Topfond Finasteride Product Portfolio
  36. 8.6.5 Henan Topfond Recent Developments
  37. 8.7 Guangdong Eashu Pharmacetical
  38. 8.7.1 Guangdong Eashu Pharmacetical Company Information
  39. 8.7.2 Guangdong Eashu Pharmacetical Business Overview
  40. 8.7.3 Guangdong Eashu Pharmacetical Finasteride Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Guangdong Eashu Pharmacetical Finasteride Product Portfolio
  42. 8.7.5 Guangdong Eashu Pharmacetical Recent Developments
  43. 8.8 RelonChem
  44. 8.8.1 RelonChem Company Information
  45. 8.8.2 RelonChem Business Overview
  46. 8.8.3 RelonChem Finasteride Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 RelonChem Finasteride Product Portfolio
  48. 8.8.5 RelonChem Recent Developments
  49. 8.9 Dr. Reddy
  50. 8.9.1 Dr. Reddy Company Information
  51. 8.9.2 Dr. Reddy Business Overview
  52. 8.9.3 Dr. Reddy Finasteride Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Dr. Reddy Finasteride Product Portfolio
  54. 8.9.5 Dr. Reddy Recent Developments
  55. 8.10 Cipla
  56. 8.10.1 Cipla Company Information
  57. 8.10.2 Cipla Business Overview
  58. 8.10.3 Cipla Finasteride Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Cipla Finasteride Product Portfolio
  60. 8.10.5 Cipla Recent Developments
  61. 8.11 Actavis
  62. 8.11.1 Actavis Company Information
  63. 8.11.2 Actavis Business Overview
  64. 8.11.3 Actavis Finasteride Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Actavis Finasteride Product Portfolio
  66. 8.11.5 Actavis Recent Developments
  67. 8.12 Accord Pharmaceuticals
  68. 8.12.1 Accord Pharmaceuticals Company Information
  69. 8.12.2 Accord Pharmaceuticals Business Overview
  70. 8.12.3 Accord Pharmaceuticals Finasteride Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Accord Pharmaceuticals Finasteride Product Portfolio
  72. 8.12.5 Accord Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Finasteride Value Chain Analysis
  2. 9.1.1 Finasteride Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Finasteride Sales Mode & Process
  6. 9.2 Finasteride Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Finasteride Distributors
  9. 9.2.3 Finasteride Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst